1. Home
  2. CSTM vs IMNM Comparison

CSTM vs IMNM Comparison

Compare CSTM & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Constellium SE (France)

CSTM

Constellium SE (France)

HOLD

Current Price

$18.40

Market Cap

2.1B

Sector

Industrials

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$19.36

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTM
IMNM
Founded
2010
2006
Country
France
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.8B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
CSTM
IMNM
Price
$18.40
$19.36
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
$19.50
$26.89
AVG Volume (30 Days)
1.1M
1.1M
Earning Date
10-29-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.79
N/A
Revenue
$7,969,000,000.00
$9,679,000.00
Revenue This Year
$9.43
N/A
Revenue Next Year
$7.41
N/A
P/E Ratio
$23.50
N/A
Revenue Growth
11.22
N/A
52 Week Low
$7.33
$5.15
52 Week High
$18.75
$20.80

Technical Indicators

Market Signals
Indicator
CSTM
IMNM
Relative Strength Index (RSI) 67.87 58.69
Support Level $17.20 $18.87
Resistance Level $18.34 $20.80
Average True Range (ATR) 0.65 1.22
MACD 0.18 -0.02
Stochastic Oscillator 90.00 70.80

Price Performance

Historical Comparison
CSTM
IMNM

About CSTM Constellium SE (France)

Constellium SE is engaged in the design and manufacture of rolled and extruded aluminium products, serving the packaging, aerospace, automotive, defence and other transportation and industry end-markets. The business is organized into three operating segments: the Packaging and Automotive Rolled Products segment which includes the production of rolled aluminium sheet products in European and North American facilities; the Aerospace and Transportation segment includes the production of rolled aluminium products and very limited volumes of extruded products in European and North American facilities; the Automotive Structures and Industry segment includes the production of extruded aluminium products and aluminium structural components.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: